US Pharma & Biotech Neuroscience - PPC Market Share Analysis March 2025

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Neuroscience category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Market Exposure

Share of Clicks for top 10 US Pharma & Biotech Neuroscience brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

See more data

Share of Clicks - Last month
Domain	Share of clicks
nurtec.com	29.11
vraylar.com	13.01
vraylarhcp.com	11.54
fanapt.com	5.66
migrelief.com	4.68
rexulti.com	4.18
caplyta.com	3.74
nurtec-hcp.com	3.29
briumvi.com	3.05
wakix.com	2.87
others	18.87

In the PPC landscape, nurtec.com leads with 29.11% click share, followed by vraylar.com at 13.01%. Vraylarhcp.com holds 11.54%, while ‘others’ collectively capture 18.87%.

Market Exposure

Share of Spend for the top 10 US Pharma & Biotech Neuroscience brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month.

See more data

Share of Spend - Last Month
Date	vraylarhcp.com	nurtec.com	wakix.com	briumvi.com	nurtec-hcp.com	migrelief.com	fanapt.com	caplyta.com	theneurologyhub.com	vraylar.com
2025/03/01	2.22%	6.52%	0.33%	1.06%	0.63%	1.23%	0.01%	11.83%	1.48%	42.12%
2025/03/02	6.43%	7.32%	1.45%	1.52%	0.92%	0.61%	0.01%	0%	1.76%	62.59%
2025/03/03	2.48%	9.06%	0.96%	0.68%	1.04%	0.64%	0%	25.07%	0.69%	34.1%
2025/03/04	2.78%	13%	0.94%	1.87%	2.65%	2.12%	2.16%	13.59%	1.96%	29.9%
2025/03/05	25.05%	26.5%	2.42%	15.67%	3.99%	3.19%	6.52%	0%	10.26%	0%
2025/03/06	4.51%	16.84%	10.14%	7.68%	3.15%	9.5%	11.52%	0%	5.39%	0%
2025/03/07	11.42%	9.06%	3.95%	4.34%	1.32%	1.17%	6.75%	9.37%	3.57%	27.12%
2025/03/08	13.4%	15.77%	5.9%	8.86%	3.54%	5.26%	6.56%	0%	3.81%	0.17%
2025/03/09	10.41%	43.77%	3.7%	6.33%	3.67%	0%	10.42%	0%	0%	0%
2025/03/10	30.23%	27.65%	3.4%	1.81%	2.82%	1.41%	17.24%	0%	1.52%	0%
2025/03/11	25.21%	30.61%	11.21%	9.06%	5.07%	2.32%	4.74%	0%	3.92%	0%
2025/03/12	13.42%	27.98%	7.26%	30.92%	4.59%	1.71%	4.01%	0%	0%	0%
2025/03/13	33.35%	24.68%	7.42%	5.81%	4.02%	4.6%	12.1%	0%	0%	0%
2025/03/14	28.14%	24.58%	8.19%	13.37%	2.93%	1.05%	6.1%	0%	3.93%	0%
2025/03/15	10.47%	36.97%	8.57%	14.11%	4.97%	4.73%	4.1%	0%	4.97%	0%
2025/03/16	26.15%	32.87%	7.28%	3.59%	3.79%	3.83%	5.13%	0%	0%	0%
2025/03/17	28.86%	32.2%	2.7%	7.76%	4.75%	7.56%	5.1%	0%	1.95%	0%
2025/03/18	28.21%	32.85%	13.86%	8.42%	5.07%	1.73%	2.71%	0%	1.86%	0%
2025/03/19	24.75%	28.67%	5.78%	3.9%	3.68%	2.78%	3.03%	0%	0%	0%
2025/03/20	20.38%	27.13%	5.57%	17.17%	3.95%	5.01%	2.33%	0%	4.74%	0%
2025/03/21	23.36%	22.99%	4.37%	6.76%	3.74%	4.22%	4.6%	0%	2.74%	0%
2025/03/22	8.45%	16.67%	6.54%	11.04%	2.43%	7.82%	6.07%	0%	6.07%	0%
2025/03/23	14.57%	26.64%	3.84%	3.55%	9.51%	3.14%	7.88%	0%	3.39%	0%
2025/03/24	11.1%	21.87%	6.69%	9.93%	12.83%	1.17%	7.72%	0%	3.5%	0%
2025/03/25	19.48%	25.46%	7.27%	6.95%	3.21%	5.56%	9.95%	0%	1.53%	0%
2025/03/26	23.12%	26.12%	6.67%	11.45%	3.98%	9.52%	6.97%	0%	0%	0%
2025/03/27	27.11%	23.74%	7.76%	5.2%	4.58%	5.69%	16.07%	0%	1.44%	0%
2025/03/28	15.41%	27.5%	10.42%	3.67%	5.24%	4.81%	11.85%	0%	1.79%	0%
2025/03/29	25.39%	30.64%	0.45%	11.35%	6.02%	7.19%	4.61%	0%	4.35%	0%
2025/03/30	11.49%	39.79%	10.73%	2.23%	4.83%	9.75%	7.01%	0%	4.57%	0%
2025/03/31	31.43%	29.36%	5.75%	5.38%	3.83%	3.48%	2.36%	0%	0%	0%

In March 2025, vraylarhcp.com saw fluctuating ad spend, peaking at 33.35 on the 13th. Nurtec.com had a significant spike on the 9th with 43.77. Vraylar.com started strong but dropped sharply by the 8th. The month ended with varied trends across domains.

Market Exposure

Competitor Count for US Pharma & Biotech Neuroscience

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month.

See more data

Competitor Count - Last month
Date	Competitor Count
2025/03/01	85
2025/03/02	90
2025/03/03	91
2025/03/04	89
2025/03/05	80
2025/03/06	91
2025/03/07	93
2025/03/08	96
2025/03/09	77
2025/03/10	72
2025/03/11	65
2025/03/12	59
2025/03/13	60
2025/03/14	70
2025/03/15	66
2025/03/16	65
2025/03/17	66
2025/03/18	63
2025/03/19	58
2025/03/20	63
2025/03/21	68
2025/03/22	67
2025/03/23	59
2025/03/24	46
2025/03/25	44
2025/03/26	46
2025/03/27	49
2025/03/28	47
2025/03/29	48
2025/03/30	51
2025/03/31	52

March began with 85 advertisers, peaking at 96 on March 8. A decline followed, reaching 44 by March 25. The month concluded with a slight recovery to 52 advertisers.

Campaign Efficiency

Market Loss & Market Gains for US Pharma & Biotech Neuroscience

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

See more data

Market Loss & Market Gains - Last month
Name	Market Trend
nurtec.com	6.47%
cobenfyhcp.com	5.64%
vraylarhcp.com	3.31%
migrelief.com	2.71%
cefaly.com	2.12%
wakixhcp.com	-0.7%
everydayhealth.com	-2.04%
caplyta.com	-3.2%
rexulti.com	-3.8%
vraylar.com	-8.76%

Nurtec.com surged with a 6.47% click share increase, while Vraylar.com plummeted by 8.76%. Cobenfyhcp.com and Vraylarhcp.com also saw positive gains.

Campaign Efficiency

US Pharma & Biotech Neuroscience Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

See more data

Date	vraylarhcp.com	nurtec.com	nurtec-hcp.com	wakix.com	briumvi.com	migrelief.com	fanapt.com	theneurologyhub.com	cobenfyhcp.com	vraylar.com
2025/03/01	3.23%	6.44%	1.55%	0.39%	1.73%	3.73%	0.01%	2.31%	1.32%	19.38%
2025/03/02	11.26%	7%	2.06%	2.81%	2.02%	2.22%	0.01%	1.99%	0.17%	33.42%
2025/03/03	6.76%	8.39%	3.48%	1.88%	1.21%	2.56%	0.01%	1.21%	0.17%	20.36%
2025/03/04	4.2%	10.98%	5.51%	1.18%	2.31%	5.48%	4.89%	2.25%	2.08%	12.74%
2025/03/05	29.74%	13.58%	7.67%	2.48%	12.32%	8.82%	10.13%	8.8%	0.06%	0%
2025/03/06	4.73%	8.34%	5.56%	10.24%	5.13%	9.17%	16.84%	4.09%	0%	0%
2025/03/07	16.62%	5.14%	3.01%	5.01%	3.62%	3.1%	12.32%	2.96%	2.26%	9.93%
2025/03/08	15.42%	7.89%	6.36%	6.17%	6.58%	11.76%	10.91%	2.73%	0%	0.05%
2025/03/09	12.13%	30.15%	7.49%	3.99%	6.59%	0.64%	15.98%	0%	0%	0%
2025/03/10	31.23%	12.21%	4.86%	3.75%	1.58%	2.78%	24.28%	1.39%	0%	0%
2025/03/11	28.88%	15.63%	9.62%	11.5%	8.54%	5.61%	8.17%	3.39%	0%	0%
2025/03/12	18.71%	14.75%	9.35%	8.25%	21.83%	3.81%	6.46%	0%	0%	0%
2025/03/13	36.03%	10.82%	6.32%	7.35%	3.92%	8.26%	18%	0%	0%	0%
2025/03/14	30.04%	11.2%	5%	8.67%	9.4%	2.67%	8.7%	2.66%	0%	0%
2025/03/15	12.39%	19.41%	9.66%	9.26%	13.26%	13.3%	6.32%	4.42%	0%	0%
2025/03/16	28.45%	16.92%	6.86%	7.05%	3.34%	7.82%	7.82%	0%	0%	0%
2025/03/17	30.85%	15.45%	8.93%	2.93%	5.57%	13.52%	7.21%	1.84%	0.58%	0%
2025/03/18	33.58%	17.03%	10.07%	13.97%	7.92%	3.94%	4.28%	1.97%	2.78%	0%
2025/03/19	25.56%	12.74%	6.07%	5.46%	3.03%	6.08%	4.16%	0%	21.49%	0%
2025/03/20	25.83%	13.24%	7.06%	5.91%	13.96%	9.88%	4.52%	4.58%	1.4%	0%
2025/03/21	28.01%	11.23%	7.03%	4.48%	5.18%	8.05%	7.4%	2.49%	8.5%	0%
2025/03/22	9.26%	6.95%	3.87%	5.82%	6.92%	13.26%	8.6%	4.07%	17.37%	0%
2025/03/23	15.82%	11.1%	13.03%	3.95%	2.91%	6.06%	9.77%	2.81%	21.38%	0%
2025/03/24	12.55%	9.21%	18.13%	6.15%	6.82%	2.2%	10.46%	2.2%	23.51%	0%
2025/03/25	20.76%	11.99%	5.83%	6.61%	4.95%	10.41%	14.9%	1.23%	10.17%	0%
2025/03/26	24.55%	12.2%	7.11%	6.08%	8.74%	18.18%	9.8%	0%	0.05%	0%
2025/03/27	29.16%	10.5%	7.41%	6.68%	4.15%	9.25%	21.25%	1.04%	0.04%	0%
2025/03/28	16.38%	12.63%	9.21%	10.78%	2.97%	11.98%	17.59%	1.44%	0.04%	0%
2025/03/29	29.6%	14.47%	10.93%	0.47%	8.72%	12.84%	6.58%	3.49%	0.04%	0%
2025/03/30	11.97%	18.59%	8.46%	10.65%	2.11%	22.14%	9.68%	4.23%	0.05%	0%
2025/03/31	38.55%	15.35%	7.73%	6.77%	5.36%	5.14%	3.42%	0%	0%	0%

In March 2025, vraylarhcp.com saw fluctuating ad impressions, peaking at 38.55% on the 31st. Nurtec.com maintained steady growth, while nurtec-hcp.com and wakix.com showed moderate increases. Cobenfyhcp.com spiked mid-month, then declined. The month ended with vraylarhcp.com leading.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Neuroscience

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

See more data

1
BRIUMVI® (ublituximab-xiiy) https://www.briumvi.com
BRIUMVI® Copay Assistance — Learn More About BRIUMVI® Treatment and Find Savings & Support. Visit Patient Site Today. FDA-Approved Treatment. Infusion Experience.
2
Suffering From Schizophrenia? Prescription treatment website
See Treatment — Learn about an FDA-approved treatment that may help adult schizophrenia symptoms. Talk to your...
3
Nurtec® ODT (rimegepant) - See How It Works https://www.nurtec.com
View efficacy data and hear from real patients taking this treatment. See study results for Nurtec ODT to learn more about treatment. Access resources.
4
VRAYLAR® (cariprazine) - Medication Information https://www.vraylar.com/
See VRAYLAR® (cariprazine) Full Prescribing Information, Including Boxed Warnings. Start the Conversation With Your Healthcare Provider About...
5
VRAYLAR® (cariprazine) https://www.vraylarhcp.com
Healthcare Professional Site — Learn About VRAYLAR®. See Full Prescribing Information, Including Boxed Warnings. See VRAYLAR® Dosing and Administration Information Here. Visit the Site to Learn More.

In the competitive landscape of pharmaceuticals, BRIUMVI® and VRAYLAR® stand out with their patient-centric messaging, emphasizing FDA approval and support. Nurtec® ODT highlights efficacy and real patient stories, while Fanapt focuses on schizophrenia treatment, showcasing a blend of empathy and information.

Frequently Asked Questions

Why are these reports useful and how should I use them?

Why these reports are useful

Imagine being able to instantly see your competitors Market Share, Share of Spend and their top performing ad copy so you can effectively benchmark your own performance.

Adthena’s PPC Market Share reports provide an instant view of performance insights across hundreds of sub-industries – so you can do just that.

How to use them
Think of these reports as a cheat sheet for your industry’s search landscape. Check out this short article for a breakdown of each report and how they can benefit your strategy.
How often is the data updated?

Data within the PPC Market Share Report 2025 is aggregated every month, highlighting the most significant changes from the previous period.
How does Adthena collect this data?

We use observed data from Google’s search results pages. With 20 million Google SERPs indexed per day. Adthena forms a global index of publicly available searches on Google.

On top of observed data, our data science models and patented technology expand on the insights through estimated metrics like market share, share of spend, and more.

We have 12 years of historical data across industries and our custom-built AI models learn from continuously updated data every day.
How accurate are these reports?

The PPC Marketing Share Report is powered by Adthena’s Whole Market View, which is the patented technology that drives value for our 300 enterprise customers.

Our unique approach to search intelligence ingests Google’s Keyword Planner into its learning models, providing a more accurate and up-to-date view of keyword data compared to traditional panel data methods.

With daily data collection and updates, Adthena offers a closer-to-real-time view of the Google Ads auction, enabling timely insights and adjustments.

Adthena focuses specifically on Google Ads, providing a deep dive into the channel and offering detailed insights into its workings. By processing 10 TB of new data daily and employing AI and machine learning models to analyze millions of Google Ads searches per second, Adthena provides a comprehensive and in-depth view of the competitive landscape.

Learn more about our data.

Learn more about our data accuracy
Does this include mobile, desktop and Google Shopping data?

Yes. The PPC Market Share Report 2025 aggregates data from across both device types and Google Shopping.
Who is this report for?

The PPC Market Share Report 2025 is for enterprise brands and agencies who want quick and high-level, historical benchmarks that are easily digestible and reveal insights, trends and market winners relevant to their own industry.
Can I get a custom report for my brand?

Our search consultants can introduce you to data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the geographies that need monitoring.

Complete the form below to get started.
What is Ask Arlo?

Ask Arlo leverages real-time GenAI to answer customers’ questions about their own search data and receive instant, tailored responses and reports directly within the Adthena platform.

With millions of Google SERPs indexed every day, Arlo never misses a trick and makes sure you’re always up to date.

Learn more about Ask Arlo.

Customer Success Stories

the7stars case study: Achieving Google Ads PPC campaign optimization with Adthena

Leveraging Adthena's comprehensive insights, the7stars and their lottery client optimized their PPC campaigns and organic strategies, resulting in substantial cost savings and improved campaign performance. Read case study

Sage case study: 75% decrease in CPCs with Adthena

Sage, a leading UK software provider, used Adthena’s brand protection strategy to curb rising CPC costs. By identifying brand infringements and optimizing spend, they effectively strengthened their brand protection strategy and increased ROI.Read case study

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Vodafone used Adthena data to optimize results from the launch of the Samsung S22 product. Combining Adthena’s Strategic Insights with Google Smart Bidding, Vodafone was able to maintain a flexible strategy that leveraged both manual and automated bidding. Leveraging Adthena’s Search Term Opportunities report also allowed Vodafone to implement 27 keyword terms across their business line, driving an increase in revenue at a positive ROAS.Read case study

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.

US Pharma & Biotech Neuroscience - PPC Market Share Analysis March 2025

Share of Clicks for top 10 US Pharma & Biotech Neuroscience brands

Share of Spend for the top 10 US Pharma & Biotech Neuroscience brands

Competitor Count for US Pharma & Biotech Neuroscience

Market Loss & Market Gains for US Pharma & Biotech Neuroscience

US Pharma & Biotech Neuroscience Share of Impressions

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Neuroscience

Frequently Asked Questions

Why are these reports useful and how should I use them?

Why these reports are useful

How often is the data updated?

How does Adthena collect this data?

How accurate are these reports?

Does this include mobile, desktop and Google Shopping data?

Who is this report for?

Can I get a custom report for my brand?

What is Ask Arlo?

Customer Success Stories

the7stars case study: Achieving Google Ads PPC campaign optimization​ with Adthena

Sage case study: 75% decrease in CPCs with Adthena

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Get the full picture

See this data specific to your brand performance

the7stars case study: Achieving Google Ads PPC campaign optimization with Adthena